Literature DB >> 10595541

Immunochemical evidence that cholesteryl ester transfer protein and bactericidal/permeability-increasing protein share a similar tertiary structure.

V Guyard-Dangremont1, V Tenekjian, V Chauhan, S Walter, P Roy, E Rassart, A R Milne.   

Abstract

Cholesteryl ester transfer protein (CETP) plays an important role in plasma lipoprotein metabolism through its ability to transfer cholesteryl ester, triglyceride, and phospholipid between lipoproteins. CETP is a member of a gene family that also includes bactericidal/permeability-increasing protein (BPI). The crystal structure of BPI shows it to be composed of two domains that share a similar structural fold that includes an apolar ligand-binding pocket. As structurally important residues are conserved between BPI and CETP, it is thought that CETP and BPI may have a similar overall conformation. We have previously proposed a model of CETP structure based on the binding characteristics of anti-CETP monoclonal antibodies (mAbs). We now present a refined epitope map of CETP that has been adapted to a structural model of CETP that uses the atomic coordinates of BPI. Four epitopes composed of CETP residues 215-219, 219-223, 223-227, and 444-450, respectively, are predicted to be situated on the external surface of the central beta-sheet and a fifth epitope (residues 225-258) on an extended linker that connects the two domains of the molecule. Three other epitopes, residues 317-331, 360-366, and 393-410, would form part of the putative carboxy-terminal beta-barrel. The ability of the corresponding mAbs to compete for binding to CETP is consistent with the proximity of the respective epitopes in the model. These results thus provide experimental evidence that is consistent with CETP and BPI having similar surface topologies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10595541      PMCID: PMC2144195          DOI: 10.1110/ps.8.11.2392

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  30 in total

1.  MOLMOL: a program for display and analysis of macromolecular structures.

Authors:  R Koradi; M Billeter; K Wüthrich
Journal:  J Mol Graph       Date:  1996-02

2.  Localization of the human phospholipid transfer protein gene to chromosome 20q12-q13.1.

Authors:  T E Whitmore; J R Day; J J Albers
Journal:  Genomics       Date:  1995-08-10       Impact factor: 5.736

3.  Complete cDNA encoding human phospholipid transfer protein from human endothelial cells.

Authors:  J R Day; J J Albers; C E Lofton-Day; T L Gilbert; A F Ching; F J Grant; P J O'Hara; S M Marcovina; J L Adolphson
Journal:  J Biol Chem       Date:  1994-03-25       Impact factor: 5.157

4.  Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels.

Authors:  S Zhong; D S Sharp; J S Grove; C Bruce; K Yano; J D Curb; A R Tall
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

Review 5.  Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin.

Authors:  R J Ulevitch; P S Tobias
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

6.  Neutralization and transfer of lipopolysaccharide by phospholipid transfer protein.

Authors:  E Hailman; J J Albers; G Wolfbauer; A Y Tu; S D Wright
Journal:  J Biol Chem       Date:  1996-05-24       Impact factor: 5.157

7.  Structure-function relationships of human cholesteryl ester transfer protein: analysis using monoclonal antibodies.

Authors:  P Roy; R MacKenzie; T Hirama; X C Jiang; P Kussie; A Tall; E Rassart; R Milne
Journal:  J Lipid Res       Date:  1996-01       Impact factor: 5.922

8.  Point mutagenesis of positively charged amino acids of cholesteryl ester transfer protein: conserved residues within the lipid transfer/lipopolysaccharide binding protein gene family essential for function.

Authors:  X C Jiang; C Bruce; T Cocke; S Wang; M Boguski; A R Tall
Journal:  Biochemistry       Date:  1995-05-30       Impact factor: 3.162

9.  Regulation of murine plasma phospholipid transfer protein activity and mRNA levels by lipopolysaccharide and high cholesterol diet.

Authors:  X C Jiang; C Bruce
Journal:  J Biol Chem       Date:  1995-07-21       Impact factor: 5.157

10.  Defective binding of neutral lipids by a carboxyl-terminal deletion mutant of cholesteryl ester transfer protein. Evidence for a carboxyl-terminal cholesteryl ester binding site essential for neutral lipid transfer activity.

Authors:  S Wang; P Kussie; L Deng; A Tall
Journal:  J Biol Chem       Date:  1995-01-13       Impact factor: 5.157

View more
  5 in total

1.  Fluoxetine-resistance genes in Caenorhabditis elegans function in the intestine and may act in drug transport.

Authors:  Robert K M Choy; John M Kemner; James H Thomas
Journal:  Genetics       Date:  2005-08-22       Impact factor: 4.562

2.  Tissue distribution of the secretory protein, SPLUNC1, in the human fetus.

Authors:  Hou-De Zhou; Song-Qin Fan; Jin Zhao; Dong-Hai Huang; Ming Zhou; Hua-Ying Liu; Zhao-Yang Zeng; Yi-Xing Yang; He Huang; Xiao-Ling Li; Shou-Rong Shen; Gui-Yuan Li
Journal:  Histochem Cell Biol       Date:  2005-09-30       Impact factor: 4.304

Review 3.  Cholesteryl ester transfer protein and its inhibitors.

Authors:  Sudichhya Shrestha; Ben J Wu; Liam Guiney; Philip J Barter; Kerry-Anne Rye
Journal:  J Lipid Res       Date:  2018-02-27       Impact factor: 5.922

4.  Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidate.

Authors:  Karen Nieto; Margit Weghofer; Peter Sehr; Mirko Ritter; Sebastian Sedlmeier; Balasubramanyam Karanam; Hanna Seitz; Martin Müller; Markus Kellner; Markus Hörer; Uwe Michaelis; Richard B S Roden; Lutz Gissmann; Jürgen A Kleinschmidt
Journal:  PLoS One       Date:  2012-06-27       Impact factor: 3.240

5.  Signaling Transduction Network Mediated by Tumor Suppressor/Susceptibility Genes in NPC.

Authors:  Minghua Wu; Xiayu Li; Xiaoling Li; Guiyuan Li
Journal:  Curr Genomics       Date:  2009-06       Impact factor: 2.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.